Literature DB >> 22521594

Paraoxonase 1 polymorphisms L55M and Q192R were not risk factors for Parkinson's disease: a HuGE review and meta-analysis.

Ying-Li Liu1, Jie Yang, Jie Zheng, Dian-Wu Liu, Tian Liu, Jian-Min Wang, Chao-Nan Wang, Ming-Wei Wang, Qing-Bao Tian.   

Abstract

PURPOSE: The Paraoxonase 1 (PON1) has been studied as a potential candidate gene for Parkinson's disease risk, but direct evidence from genetic association studies remains inconclusive. We performed a meta-analysis pooling data from all relevant studies in order to determine the effects of two PON 1 polymorphisms (L55M and Q192R) on Parkinson's disease.
METHODS: We applied a random effects to combine odds ratio (OR) and 95% confidence intervals. Q statistic was used to evaluate the homogeneity, and Egger's test and Funnel plot were used to assess publication bias. In secondary analyses, we examined dominant and recessive models as well.
RESULTS: Concerning the PON1 L55M polymorphism, we identified 9 eligible studies (a total of 2582 cases and 3997 controls). The random effects pooled OR was OR=1.29, (0.90, 1.84). Concerning the Q192R polymorphism, we identified 7 eligible studies (a total of 2582 cases and 3997 controls). The random effects pooled OR was OR=1.08(0.81, 1.43). Analysis with dominant and recessive genetic models yielded the same inferences as genotype-based comparisons for both of the two polymorphisms.
CONCLUSION: The results of this meta-analysis suggested that both PON1 L55M and Q192R were not responsible for PD.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22521594     DOI: 10.1016/j.gene.2012.03.067

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  9 in total

Review 1.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

2.  Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.

Authors:  Alshaymaa Ahmed Ibrahim; Dalia El-Lebedy; Ingy Ashmawy; Maha Abdel Hady
Journal:  Clin Rheumatol       Date:  2017-02-09       Impact factor: 2.980

Review 3.  Of Pesticides and Men: a California Story of Genes and Environment in Parkinson's Disease.

Authors:  Beate R Ritz; Kimberly C Paul; Jeff M Bronstein
Journal:  Curr Environ Health Rep       Date:  2016-03

4.  Organophosphate pesticides and PON1 L55M in Parkinson's disease progression.

Authors:  Kimberly C Paul; Janet S Sinsheimer; Myles Cockburn; Jeff M Bronstein; Yvette Bordelon; Beate Ritz
Journal:  Environ Int       Date:  2017-07-06       Impact factor: 9.621

5.  Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure.

Authors:  Pei-Chen Lee; Shannon L Rhodes; Janet S Sinsheimer; Jeff Bronstein; Beate Ritz
Journal:  Environ Int       Date:  2013-04-16       Impact factor: 9.621

Review 6.  Paraoxonase 1 in neurological disorders.

Authors:  Teresita Menini; Alejandro Gugliucci
Journal:  Redox Rep       Date:  2013-11-12       Impact factor: 4.412

7.  An Enriched Environment Ameliorates Oxidative Stress and Olfactory Dysfunction in Parkinson's Disease with α-Synucleinopathy.

Authors:  Soohyun Wi; Jang Woo Lee; MinGi Kim; Chang-Hwan Park; Sung-Rae Cho
Journal:  Cell Transplant       Date:  2018-04-30       Impact factor: 4.064

8.  Paraoxonase 3 gene polymorphisms are associated with occupational noise-induced deafness: A matched case-control study from China.

Authors:  Huaping Zhou; Jinpeng Zhou; Hui Li; Changye Hui; Jing Bi
Journal:  PLoS One       Date:  2020-10-15       Impact factor: 3.240

Review 9.  HDL Accessory Proteins in Parkinson's Disease-Focusing on Clusterin (Apolipoprotein J) in Regard to Its Involvement in Pathology and Diagnostics-A Review.

Authors:  Izabela Berdowska; Małgorzata Matusiewicz; Małgorzata Krzystek-Korpacka
Journal:  Antioxidants (Basel)       Date:  2022-03-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.